发明名称 |
GENISTEIN CANCER TREATMENT REGIMEN MAXIMIZING CANCER RADIATION THERAPY BENEFITS |
摘要 |
A treatment regimen for a patient undergoing fractionated radiation therapy for a solid tumor type cancer to attain an improvement in one or more of and an optimized balancing of cancer cell radiation sensitization, normal cell radioprotection, selective post-exposure inhibition of cancer cell recovery relative to normal cell recovery, and stabilization of body weight during radiation treatment. The regimen comprises administration of a therapeutic amount of genistein to a patient diagnosed with a solid tumor type cancer throughout an administration period that commences at least five days prior to commencement of fractionated cancer radiation therapy and extends until at least the conclusion of fractionated cancer radiation therapy. |
申请公布号 |
US2015126597(A1) |
申请公布日期 |
2015.05.07 |
申请号 |
US201314074468 |
申请日期 |
2013.11.07 |
申请人 |
Humanetics Corporation |
发明人 |
Kaytor Michael D.;Zenk John L. |
分类号 |
A61K31/352 |
主分类号 |
A61K31/352 |
代理机构 |
|
代理人 |
|
主权项 |
1. A treatment regimen for a patient undergoing fractionated radiation therapy for a solid tumor type cancer, comprising administration of a therapeutic amount of genistein to a patient diagnosed with a solid tumor type cancer throughout an administration period that commences at least five days prior to commencement of fractionated cancer radiation therapy and extends until at least the conclusion of fractionated cancer radiation therapy. |
地址 |
Minneapolis MN US |